Literature DB >> 20141570

Functional and physical interactions between formyl-peptide-receptors and scavenger receptor MARCO and their involvement in amyloid beta 1-42-induced signal transduction in glial cells.

Lars-Ove Brandenburg1, Maximilian Konrad, Christoph J Wruck, Thomas Koch, Ralph Lucius, Thomas Pufe.   

Abstract

Recent studies suggest that the chemotactic G protein-coupled receptor formyl-peptide-receptor-like-1 (FPRL1) or the scavenger receptor MARCO (macrophage receptor with collagenous structure) plays an essential role in the inflammatory response of host defense mechanisms and neurodegenerative disorders such as Alzheimer's disease. We therefore analyzed the involvement of FPRL1 and MARCO in amyloid beta1-42 (Abeta1-42)-induced signalling by extracellular-signal regulated kinases 1/2 (ERK1/2) phosphorylation and cAMP level measurement in glial cells (astrocytes and microglia) and in transfected HEK293 cells. Receptors were inhibited by small interference RNA and the consequences in Abeta1-42- and MARCO agonist fucoidan-induced signal transduction were determined. Receptor deactivation by antagonists or small interference RNA verified the importance of FPRL1 for Abeta1-42-mediated signal transduction by ERK1/2 phosphorylation and cAMP level measurement in glial cells. Furthermore, for the first time, we have demonstrated a functional interaction between FPRL1 and scavenger receptors in fucoidan-mediated signalling by ERK1/2 phosphorylation and cAMP level measurement. In addition, co-immunoprecipitation data and fluorescence microscopy measurements revealed a physical interaction between FPR, FPRL1 and MARCO. These results suggest that FPRL1 plays a pivotal role for Abeta1-42-induced signal transduction in glial cells and the interaction with MARCO could explain the broad ligand spectrum of formyl peptide receptors.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20141570     DOI: 10.1111/j.1471-4159.2010.06637.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  34 in total

Review 1.  Expression and signaling of formyl-peptide receptors in the brain.

Authors:  Fabio Cattaneo; Germano Guerra; Rosario Ammendola
Journal:  Neurochem Res       Date:  2010-11-02       Impact factor: 3.996

Review 2.  Microglial Aβ receptors in Alzheimer's disease.

Authors:  Yang Yu; Richard D Ye
Journal:  Cell Mol Neurobiol       Date:  2014-08-23       Impact factor: 5.046

3.  Lack of formyl peptide receptor 1 and 2 leads to more severe inflammation and higher mortality in mice with of pneumococcal meningitis.

Authors:  Sandra Oldekamp; Sebastian Pscheidl; Eugenia Kress; Oliver Soehnlein; Sandra Jansen; Thomas Pufe; Ji Ming Wang; Simone C Tauber; Lars-Ove Brandenburg
Journal:  Immunology       Date:  2014-11       Impact factor: 7.397

4.  FPR2/ALX receptor expression and internalization are critical for lipoxin A4 and annexin-derived peptide-stimulated phagocytosis.

Authors:  Paola Maderna; David C Cottell; Tiina Toivonen; Neil Dufton; Jesmond Dalli; Mauro Perretti; Catherine Godson
Journal:  FASEB J       Date:  2010-06-22       Impact factor: 5.191

5.  Proinflammatory stimulants promote the expression of a promiscuous G protein-coupled receptor, mFPR2, in microvascular endothelial cells.

Authors:  Haiwei Mou; Zongmeng Li; Yan Kong; Bo Deng; Lihua Qian; Ji Ming Wang; Yingying Le
Journal:  Inflammation       Date:  2012-04       Impact factor: 4.092

6.  Annexin A1: a central player in the anti-inflammatory and neuroprotective role of microglia.

Authors:  Simon McArthur; Enrico Cristante; Mario Paterno; Helen Christian; Federico Roncaroli; Glenda E Gillies; Egle Solito
Journal:  J Immunol       Date:  2010-10-20       Impact factor: 5.422

7.  Expression and function of psoriasin (S100A7) and koebnerisin (S100A15) in the brain.

Authors:  Sandra Jansen; Rainer Podschun; Stephen L Leib; Joachim Grötzinger; Stefanie Oestern; Matthias Michalek; Thomas Pufe; Lars-Ove Brandenburg
Journal:  Infect Immun       Date:  2013-03-11       Impact factor: 3.441

8.  Fucoidan is a novel platelet agonist for the C-type lectin-like receptor 2 (CLEC-2).

Authors:  Bhanu Kanth Manne; Todd M Getz; Craig E Hughes; Osama Alshehri; Carol Dangelmaier; Ulhas P Naik; Steve P Watson; Satya P Kunapuli
Journal:  J Biol Chem       Date:  2013-01-22       Impact factor: 5.157

9.  3-(1H-indol-3-yl)-2-[3-(4-nitrophenyl)ureido]propanamide enantiomers with human formyl-peptide receptor agonist activity: molecular modeling of chiral recognition by FPR2.

Authors:  Igor A Schepetkin; Liliya N Kirpotina; Andrei I Khlebnikov; Marcello Leopoldo; Ermelinda Lucente; Enza Lacivita; Paola De Giorgio; Mark T Quinn
Journal:  Biochem Pharmacol       Date:  2012-12-03       Impact factor: 5.858

Review 10.  Innate immunity in Alzheimer's disease: a complex affair.

Authors:  Marie-Victoire Guillot-Sestier; Terrence Town
Journal:  CNS Neurol Disord Drug Targets       Date:  2013-08       Impact factor: 4.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.